TABLE 2A.

Baseline demographics and clinical characteristics of participants with reduced accommodative amplitude by treatment group

	Vergence/Accommodative Therapy (N = 115)	Placebo Therapy (N = 65)	Overall (N = 180)
Age (years), mean (SD)	10.8 (1.5)	10.9 (1.4)	10.8 (1.4)
Sex, female, N (%)	75 (65)	34 (52)	109 (61)
White Race, N (%)	71 (62)	35 (54)	106 (59)
Hispanic or Latino Ethnicity, N (%)	39 (34)	23 (36)	62 (34)
Convergence Insufficiency Symptom Survey score, mean (SD)	30.3 (8.6)	31.9 (8.9)	30.9 (8.7)
Monocular Accommodative Amplitude (D), mean (SD)	7.6 (1.7)	7.1 (1.7)	7.4 (1.7)
Monocular Accommodative Facility (cpm), mean (SD)	6.8 (4.2)	6.8 (5)	6.8 (4.5)
Exodeviation at distance (Δ), mean (SD)	1.9 (2.7)	2.2 (4.3)	2.0 (3.4)
Exodeviation at near (Δ), mean (SD)	9.9 (4.1)	10.0 (5.7)	10.0 (4.7)
Near Point of Convergence Break (cm), mean (SD)	16.0 (8.3)	17.0 (8.2)	16.4 (8.2)
Positive Fusional Vergence Blur/Break† (Δ), mean (SD)	10.7 (4.1)	11.3 (4.2)	10.9 (4.2)

^†The blur finding was used, but if blur was not reported, the break finding was used.

SD = standard deviation; D = diopters; cpm = cycles per minute; Δ = prism diopters.